NIQ Global Intelligence plc has officially filed for an IPO in 2025, setting the stage for one of the most anticipated public listings of the year. Here's a detailed, plain-English breakdown of what this move means for the market and potential investors.

The tech industry is about to witness one of its most significant mergers in recent history. Synopsys, a titan in semiconductor design, is acquiring Ansys, a leader in simulation software. With a deal valued at $35 billion, this merger is set to create a powerful force at the intersection of electronics and physics.

Accelerant Holdings is set to go public. Discover key IPO facts, financials, investor insights, and how this insurance platform is positioning itself for long-term growth.

Liberty Broadband Corporation is making waves in the market with its decision to spin off GCI Liberty, Inc. This separation marks a significant milestone for both companies as they prepare to pursue more focused strategic goals. If you're an investor or just a curious onlooker, this guide will walk you through everything that’s happening, when it’s happening, and what you need to watch for.

In a bold strategic move, Novartis is acquiring Regulus Therapeutics for up to $1.8 billion. The acquisition centers around farabursen, a novel RNA-based therapy poised to disrupt treatment options for a serious kidney condition called ADPKD. Here's a deep dive into what this merger means for the future of biotech and patient care.

The New Home Company and Landsea Homes have reached a definitive merger agreement valued at approximately $1.2 billion, under which Landsea shareholders will receive $11.30 per share in cash, representing a 61 percent premium to the May 12, 2025 closing price. Backed by Apollo Global Management, this all-cash deal will create a privately held, top-25 national homebuilder with a diversified, asset-light platform spanning ten high-growth markets.

Servotronics and TransDigm have amended their merger agreement to boost the cash tender offer price to $47.00 per share following an unsolicited acquisition proposal. Here is a detailed look at the timeline, mechanics, board endorsement, and what investors should consider.

Holcim’s spin-off of its North American business into Amrize marks the birth of the continent’s preeminent building solutions firm. Learn about the transaction’s regulatory steps, financial structuring, market positioning, and what it means for investors and the construction industry.

SRM Entertainment has transformed itself into Tron Inc through a strategic reverse merger, backed by a $100 million equity infusion paid in TRX, a landmark advisory deal with TRON founder Justin Sun, and a blueprint for a TRX Treasury Strategy. In this article, we’ll explore the deal mechanics, what they mean for shareholders, and the path ahead as Tron Inc stakes its claim in the blockchain frontier.

In a landmark deal announced in May 2025, Kronos Bio, Inc. agreed to be acquired by Concentra Biosciences for $0.57 per share in cash plus one contingent value right per share. This comprehensive guide unpacks the transaction’s background, key terms, strategic drivers, and what it means for Kronos’s investors and the broader biotech mergers 2025 landscape.

Jefferson Capital, Inc. is gearing up for its IPO on the Nasdaq Global Select Market under the ticker JCAP. The offering comprises 10 million shares priced between $15 and $17, positioning this specialty finance IPO as a key event in Nasdaq IPO 2025. Investors are eyeing the strong growth in Jefferson Capital’s portfolio revenues and the backing of J.C. Flowers & Co.

Redfin and Rocket Companies have agreed to a major merger that could redefine digital real estate. Here's what investors and industry watchers need to know.

The aerospace and defense sector is buzzing with the upcoming AIRO Group Holdings IPO. Set to debut on the Nasdaq under the ticker "AIRO," this emerging growth company is aiming to raise capital through a 5 million share offering. Here's what investors need to know.

JBS, the global meat processing giant, is shaking up the financial world with its ambitious IPO strategy. The company is undergoing a major corporate restructuring to form JBS N.V., set for a dual listing on the New York Stock Exchange and Brazil’s B3 exchange. But what does this really mean for investors and stakeholders?

Caris Life Sciences, a pioneer in molecular diagnostics and AI-driven precision oncology, is gearing up to go public. With a multi-million-dollar IPO on the horizon, investors and analysts alike are taking a close look at the company’s financials, technology, and growth potential. Here’s your in-depth guide to the Caris IPO, ticker symbol CAI.

Slide Insurance Holdings, Inc. is stepping into the public markets with a tech-driven twist on traditional insurance. Here's a deep dive into everything you need to know about their upcoming IPO.

Ategrity Specialty Insurance Company Holdings is stepping into the public market spotlight with its 2025 IPO. Here's a quick breakdown of what investors should know about this emerging insurer and its ambitious NYSE listing under the ticker “ASIC.”

Voyager Technologies, Inc. is officially going public. With a promising offering and big names backing the launch, this IPO could shake up the tech investment landscape in 2025. Here's everything you need to know about the VOYG IPO.

Omada Health is officially stepping into the public market. With a proposed offering of 7.5 million shares and a mission to transform digital healthcare, investors are paying close attention. But is it the right move for your portfolio?

Chime Financial is set to hit the public markets with its 2025 IPO. Learn all the critical details from share structure to listing plans and more.